Graves J W
Division of Hypertension and Internal Medicine, Mayo Clinic Rochester, MN 55905, USA.
Mayo Clin Proc. 2000 Mar;75(3):278-84. doi: 10.4065/75.3.278.
Hypertension is a primary risk factor for heart disease and stroke, the first and third most common causes of death in the United States. The National Health and Nutrition Examination Survey (NHANES) revealed an increase in awareness of hypertension from 51% to 73%, and, among persons with hypertension, the treatment rate has increased from 31% to 55% (from 1976-1980 vs 1988-1991). Of importance, the rate of those achieving goal blood pressure (< 140/90 mm Hg) has only improved from 10% in NHANES-II (1976-1980) to 29% in NHANES-III (1988-1991). Thus, more than 70% of persons with hypertension in whom good blood pressure control has not been achieved are termed "difficult hypertensives." Failure to achieve treatment blood pressure goals of less than 140/90 mm Hg is usually attributed to the presence of resistant hypertension, a resistant physician, secondary causes of hypertension such as renovascular disease, medication adverse effects, or a nonadherent patient. A practical understanding of the pathophysiology of resistant hypertension, appropriate screening techniques for secondary forms of hypertension, and alternative management strategies for a chronic disease such as hypertension can result in treatment goals being achieved in most difficult hypertensives.
高血压是心脏病和中风的主要危险因素,而心脏病和中风是美国第一和第三大常见死因。美国国家健康与营养检查调查(NHANES)显示,高血压知晓率从51%上升至73%,并且在高血压患者中,治疗率从31%升至55%(1976 - 1980年与1988 - 1991年相比)。重要的是,血压达标(< 140/90 mmHg)的比率仅从NHANES - II(1976 - 1980年)的10%提高到NHANES - III(1988 - 1991年)的29%。因此,超过70%未实现良好血压控制的高血压患者被称为“难治性高血压患者”。未能达到低于140/90 mmHg的治疗血压目标通常归因于顽固性高血压的存在、固执的医生、高血压的继发性原因(如肾血管疾病)、药物不良反应或不依从的患者。对抗性高血压的病理生理学有实际的了解、对继发性高血压形式采用适当的筛查技术以及对高血压等慢性疾病采用替代管理策略,可使大多数难治性高血压患者实现治疗目标。